Cargando…

Vancomycin and High Level Aminoglycoside Resistance in Enterococcus spp. in a Tertiary Health Care Centre: A Therapeutic Concern

Aims. This study was aimed at knowing the prevalence of vancomycin and high level aminoglycoside resistance in enterococcal strains among clinical samples. Study Design. It was an investigational study. Place and Duration of Study. It was conducted on 100 Enterococcus isolates, in the Department of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mittal, Seema, Singla, Pooja, Deep, Antariksha, Bala, Kiran, Sikka, Rama, Garg, Meenu, Chaudhary, Uma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800106/
https://www.ncbi.nlm.nih.gov/pubmed/27047693
http://dx.doi.org/10.1155/2016/8262561
_version_ 1782422433119076352
author Mittal, Seema
Singla, Pooja
Deep, Antariksha
Bala, Kiran
Sikka, Rama
Garg, Meenu
Chaudhary, Uma
author_facet Mittal, Seema
Singla, Pooja
Deep, Antariksha
Bala, Kiran
Sikka, Rama
Garg, Meenu
Chaudhary, Uma
author_sort Mittal, Seema
collection PubMed
description Aims. This study was aimed at knowing the prevalence of vancomycin and high level aminoglycoside resistance in enterococcal strains among clinical samples. Study Design. It was an investigational study. Place and Duration of Study. It was conducted on 100 Enterococcus isolates, in the Department of Microbiology, Pt. BDS PGIMS, Rohtak, over a period of six months from July to December 2014. Methodology. Clinical specimens including urine, pus, blood, semen, vaginal swab, and throat swab were processed and Enterococcus isolates were identified by standard protocols. Antibiotic sensitivity testing of enterococci was performed using Kirby-Bauer disc diffusion method. Results. High level gentamicin resistance (HLGR) was more common in urine samples (41.5%) followed by blood (36%) samples. High level streptomycin resistance (HLSR) was more common in pus samples (52.6%) followed by blood samples (36%). Resistance to vancomycin was maximum in blood isolates. Conclusion. Enterococci resistant to multiple antimicrobial agents have been recognized. Thus, it is crucial for laboratories to provide accurate antimicrobial resistance patterns for enterococci so that effective therapy and infection control measures can be initiated.
format Online
Article
Text
id pubmed-4800106
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-48001062016-04-04 Vancomycin and High Level Aminoglycoside Resistance in Enterococcus spp. in a Tertiary Health Care Centre: A Therapeutic Concern Mittal, Seema Singla, Pooja Deep, Antariksha Bala, Kiran Sikka, Rama Garg, Meenu Chaudhary, Uma J Pathog Research Article Aims. This study was aimed at knowing the prevalence of vancomycin and high level aminoglycoside resistance in enterococcal strains among clinical samples. Study Design. It was an investigational study. Place and Duration of Study. It was conducted on 100 Enterococcus isolates, in the Department of Microbiology, Pt. BDS PGIMS, Rohtak, over a period of six months from July to December 2014. Methodology. Clinical specimens including urine, pus, blood, semen, vaginal swab, and throat swab were processed and Enterococcus isolates were identified by standard protocols. Antibiotic sensitivity testing of enterococci was performed using Kirby-Bauer disc diffusion method. Results. High level gentamicin resistance (HLGR) was more common in urine samples (41.5%) followed by blood (36%) samples. High level streptomycin resistance (HLSR) was more common in pus samples (52.6%) followed by blood samples (36%). Resistance to vancomycin was maximum in blood isolates. Conclusion. Enterococci resistant to multiple antimicrobial agents have been recognized. Thus, it is crucial for laboratories to provide accurate antimicrobial resistance patterns for enterococci so that effective therapy and infection control measures can be initiated. Hindawi Publishing Corporation 2016 2016-03-07 /pmc/articles/PMC4800106/ /pubmed/27047693 http://dx.doi.org/10.1155/2016/8262561 Text en Copyright © 2016 Seema Mittal et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mittal, Seema
Singla, Pooja
Deep, Antariksha
Bala, Kiran
Sikka, Rama
Garg, Meenu
Chaudhary, Uma
Vancomycin and High Level Aminoglycoside Resistance in Enterococcus spp. in a Tertiary Health Care Centre: A Therapeutic Concern
title Vancomycin and High Level Aminoglycoside Resistance in Enterococcus spp. in a Tertiary Health Care Centre: A Therapeutic Concern
title_full Vancomycin and High Level Aminoglycoside Resistance in Enterococcus spp. in a Tertiary Health Care Centre: A Therapeutic Concern
title_fullStr Vancomycin and High Level Aminoglycoside Resistance in Enterococcus spp. in a Tertiary Health Care Centre: A Therapeutic Concern
title_full_unstemmed Vancomycin and High Level Aminoglycoside Resistance in Enterococcus spp. in a Tertiary Health Care Centre: A Therapeutic Concern
title_short Vancomycin and High Level Aminoglycoside Resistance in Enterococcus spp. in a Tertiary Health Care Centre: A Therapeutic Concern
title_sort vancomycin and high level aminoglycoside resistance in enterococcus spp. in a tertiary health care centre: a therapeutic concern
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800106/
https://www.ncbi.nlm.nih.gov/pubmed/27047693
http://dx.doi.org/10.1155/2016/8262561
work_keys_str_mv AT mittalseema vancomycinandhighlevelaminoglycosideresistanceinenterococcussppinatertiaryhealthcarecentreatherapeuticconcern
AT singlapooja vancomycinandhighlevelaminoglycosideresistanceinenterococcussppinatertiaryhealthcarecentreatherapeuticconcern
AT deepantariksha vancomycinandhighlevelaminoglycosideresistanceinenterococcussppinatertiaryhealthcarecentreatherapeuticconcern
AT balakiran vancomycinandhighlevelaminoglycosideresistanceinenterococcussppinatertiaryhealthcarecentreatherapeuticconcern
AT sikkarama vancomycinandhighlevelaminoglycosideresistanceinenterococcussppinatertiaryhealthcarecentreatherapeuticconcern
AT gargmeenu vancomycinandhighlevelaminoglycosideresistanceinenterococcussppinatertiaryhealthcarecentreatherapeuticconcern
AT chaudharyuma vancomycinandhighlevelaminoglycosideresistanceinenterococcussppinatertiaryhealthcarecentreatherapeuticconcern